Hematology Advisor

Latest

Combining Ruxolitinib With Donor Regulatory T Cells May Outperform Monotherapy in Chronic Graft Vs Host Disease

Bax/Bcl-2 Expression in Pediatric Acute Lymphoblastic Leukemia

Anticoagulation in Non-ICU Patients With COVID-19 at High Thrombosis Risk

Combo Produces High Response Rate in Older Adults With Ph-Negative B-ALL

Four in 10 U.S. Adults Not Comfortable Performing CPR

Use of a Smart Medical Internet of Things System on Quality of Life in Patients With Hemophilia

Antithrombotic Treatment Resistance in Multiple Myeloma Likely Multifactorial

Discordance in Symptomatic Adverse Event Reports by Clinicians, Children in Cancer Clinical Trials

Thromboembolic Events Among Patients Hospitalized With COVID-19 Pneumonia

Donor Sex, Parity Do Not Up Mortality for Red Blood Cell Recipients

HCVAD Induced High Response Rates in Blastic Plasmacytoid Dendritic Cell Neoplasm

Long-Term Efficacy of Zanubrutinib Confirmed for Mantle Cell Lymphoma

Parsaclisib May Be Safe, Effective in Autoimmune Hemolytic Anemia

FDA Aims To Improve Medical Device Security

The agency has issued proposed draft recommendations to guide incorporation of cybersecurity protections into medical devices at the time of manufacture.

Radiomics: An Emerging Frontier in Cancer Diagnostics, Treatment Planning

This overview of radiomics explains its potential for improving diagnosis, predictions of tumor response and recurrence, and patient prognosis.

Risk of Cancer-Specific Death May Remain Elevated for 30 Years

Patients with certain cancers have an increased risk of cancer-specific mortality that persists for 30 to 35 years after diagnosis.

Depression is experienced by many patients after a cancer diagnosis.

Addressing Psychological Distress After VTE

Researchers are seeking to address the psychological impact of patients who have survived VTE.

Browse drugs by:

Brand Generic Disease